IRVINE, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, is scheduled to participate in the Credit Suisse First Boston Annual Healthcare Conference at the Arizona Biltmore Resort and Spa in Phoenix, AZ on November 16, 2005.
Larry L. Wood, Edwards Lifesciences’ vice president, general manager of Percutaneous Valve Interventions - Replacement, will speak to the attendees of the conference at 10:30 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences’ investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards’ investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company’s global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT, and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office.
Edwards Lifesciences
CONTACT: Investors, David K. Erickson, +1-949-250-6826, or Media, Barry R.Liden, +1-949-250-5070, both of Edwards Lifesciences
